I am responsible for the care of HIV-infected and exposed children at my hospital in Curicica, Rio de Janeiro, Brazil. We have about 70 infected children. I care for an 11-year-old girl who was ...
HealthDay News — Therapy with a human antibody appears to reduce levels of HIV in the blood for at least a month, preliminary research findings suggest. The antibody “might be able to intensify ...
A Phase 1 clinical trial provides promising results for a broadly neutralizing antibody (bnAb) HIV vaccine, according to a new study. The findings of this first-in-humans test establish a clinical ...
A small study found that 2 broadly neutralizing anti-HIV antibodies could help achieve long-term virological suppression in patients with HIV who were taken off antiretroviral therapy. People living ...
The discovery of broadly neutralizing antibodies (bNAbs) like b12 in 1994 marked a turning point in HIV research. B12 ...
Background. Human immunodeficiency virus (HIV) antibodies are generated and maintained by ongoing systemic expression of HIV antigen. We investigated whether HIV antibody responses as measured by high ...
New research found that people living with HIV that have had pulmonary tuberculosis had broader and more potent HIV antibody responses and differences in HIV sequences predicted to be antibody ...
The finding provides further evidence that antibodies—specialized proteins that the body produces to fight infections—could one day be used as a method to prevent people from becoming infected with ...
When children living with HIV are injected with neutralizing antibodies, the treatment can suppress cells that contain the virus and are capable of reactivating, an early-stage trial found. Details of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback